Criminal & Civil Justice News

Jurors to hear closing arguments in deadly meningitis trial


In this Dec. 19, 2014, file photo, Barry Cadden leaves the federal courthouse in Boston after a hearing. Closing arguments are scheduled Thursday, March 16, 2017 in his trial. Cadden, a former pharmacy executive and the president of New England Compounding Center, is charged with causing the deaths in 2012 of 25 people who received tainted steroids manufactured by the pharmacy. (AP Photo/Stephan Savoia, File)

In this Dec. 19, 2014, file photo, Barry Cadden leaves the federal courthouse in Boston after a hearing. Closing arguments are scheduled Thursday, March 16, 2017 in his trial. Cadden, a former pharmacy executive and the president of New England Compounding Center, is charged with causing the deaths in 2012 of 25 people who received tainted steroids manufactured by the pharmacy. (AP Photo/Stephan Savoia, File)

BOSTON (AP) — Jurors are set to hear closing arguments in the trial of a former pharmacy executive charged in a deadly national meningitis outbreak traced to tainted steroids made by a Massachusetts compounding pharmacy.

Barry Cadden is charged with 25 counts of second-degree murder under federal racketeering laws.

Prosecutors allege that Cadden — the former president of the New England Compounding Center — ignored repeated warning signs that drugs manufactured by his company were being contaminated by mold.

The 2012 outbreak killed 64 people and sickened about 700 others.

Cadden’s lawyer says that prosecutors are trying to blame Cadden for mistakes made by other employees, including pharmacists and technicians.

Prosecutors say Cadden was responsible for making sure industry rules for sterility and cleanliness were followed.

Closing arguments are scheduled for Thursday.

Source: AP

Copyright 2016 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Share this post!
Facebook Twitter Linkedin Email Pinterest

Comments

tab  

Your email address will not be published. Required fields are marked *